Disruptive NADSYN1 Variants Implicated in Congenital Vertebral Malformations.
Ontology highlight
ABSTRACT: Genetic perturbations in nicotinamide adenine dinucleotide de novo (NAD) synthesis pathway predispose individuals to congenital birth defects. The NADSYN1 encodes the final enzyme in the de novo NAD synthesis pathway and, therefore, plays an important role in NAD metabolism and organ embryogenesis. Biallelic mutations in the NADSYN1 gene have been reported to be causative of congenital organ defects known as VCRL syndrome (Vertebral-Cardiac-Renal-Limb syndrome). Here, we analyzed the genetic variants in NADSYN1 in an exome-sequenced cohort consisting of patients with congenital vertebral malformations (CVMs). A total number of eight variants in NADSYN1, including two truncating variants and six missense variants, were identified in nine unrelated patients. All e
SUBMITTER: Lin J
PROVIDER: S-EPMC8535205 | biostudies-literature | 2021 Oct
REPOSITORIES: biostudies-literature
ACCESS DATA